These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2524238)

  • 1. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG; McGeer EG; McGeer PL
    Brain Res; 1989 Mar; 481(2):356-60. PubMed ID: 2524238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements.
    Susel Z; Engber TM; Chase TN
    Neurosci Lett; 1989 Sep; 104(1-2):125-9. PubMed ID: 2530473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine protects against kainate but not ibotenate lesions in rat striatum.
    McGeer EG; Zhu SG
    Neurosci Lett; 1990 May; 112(2-3):348-51. PubMed ID: 2141673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats.
    Yamada K; Fuji K; Nabeshima T; Kameyama T
    Neurosci Lett; 1990 Oct; 118(1):128-31. PubMed ID: 2147984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.
    Foster AC; Vezzani A; French ED; Schwarcz R
    Neurosci Lett; 1984 Aug; 48(3):273-8. PubMed ID: 6237279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum.
    Norman AB; Ford LM; Kolmonpunporn M; Sanberg PR
    Eur J Pharmacol; 1990 Feb; 176(3):363-6. PubMed ID: 2139415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC; Gill R; Woodruff GN
    J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease.
    Susel Z; Engber TM; Kuo S; Chase TN
    Neurosci Lett; 1991 Jan; 121(1-2):234-8. PubMed ID: 1826944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH).
    McGeer EG; Singh E
    Exp Neurol; 1984 Nov; 86(2):410-3. PubMed ID: 6436049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum.
    Norman AB; Ford LM; Sanberg PR
    Exp Neurol; 1991 Oct; 114(1):132-5. PubMed ID: 1680744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum.
    Willis CL; Brazell C; Foster AC
    Eur J Pharmacol; 1991 Apr; 196(3):285-90. PubMed ID: 1832637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat.
    Lombardi G; Zanoni R; Moroni F
    Eur J Pharmacol; 1989 Dec; 174(1):123-5. PubMed ID: 2612575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinolinate neurotoxicity and glutamatergic structures.
    Keilhoff G; Wolf G; Stastný F; Schmidt W
    Neuroscience; 1990; 34(1):235-42. PubMed ID: 1970138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo.
    Schoepp DD; Salhoff CR; Hillman CC; Ornstein PL
    J Neural Transm Gen Sect; 1989; 78(3):183-93. PubMed ID: 2553073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum.
    Krebs MO; Kemel ML; Gauchy C; Desban M; Glowinski J
    Eur J Pharmacol; 1989 Aug; 166(3):567-70. PubMed ID: 2680525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.
    Jhamandas K; Boegman RJ; Beninger RJ; Bialik M
    Brain Res; 1990 Oct; 529(1-2):185-91. PubMed ID: 2149296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of tryptophan metabolites.
    Boegman RJ; Jhamandas K; Beninger RJ
    Ann N Y Acad Sci; 1990; 585():261-73. PubMed ID: 2141454
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
    Ceresoli-Borroni G; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.